Effectiveness and Safety of Early Botulinum Toxin Injections to Prevent Shoulder Deformity in Babies with Obstetrical Brachial Plexus Palsy
Led by University Hospital, Brest · Updated on 2026-03-20
62
Participants Needed
7
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
This trial focuses on babies with obstetrical brachial plexus palsy OBPP, a condition causing shoulder muscle deformity that leads to reduced shoulder movement, pain, and social participation difficulties. Researchers are studying whether early injections of botulinum toxin type A BTI into the shoulder muscles at 12 months of age can prevent worsening shoulder deformities compared to a simulated sham procedure. The study is designed as a randomized, double-blind clinical trial sponsored by University Hospital, Brest.
Participants are randomly assigned to receive either the botulinum toxin injection or a sham injection at 12 months old. The botulinum toxin dose is 8 UIkg, divided among specific shoulder muscles. The sham group undergoes a simulated injection mimicking the procedure without the active drug. The study measures effects at 11 months before injection and at 18 months six months after injection, with long-term follow-up until 10 years old to assess surgical intervention frequency.
Throughout the study, babies will undergo MRI scans to measure shoulder joint positioning and assess muscle condition. Researchers will also evaluate shoulder movement range, upper limb function, and treatment tolerance. The primary outcome is the change in shoulder joint position between 11 and 18 months. Secondary outcomes include muscle condition, joint deformity, and the need for surgery over time. Participation involves clinical assessments and imaging at specific ages, with safety and effectiveness monitored closely.
CONDITIONS
Brief Title
Effectiveness and Safety of Early Intramuscular Botulinum Toxin Injections to Prevent Shoulder Deformity in Babies With Obstetrical Brachial Plexus Palsy
Research Team
S
Sylvain Brochard, Pr
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Male and female babies with unilateral obstetrical brachial plexus palsy (OBPP)
Age between 10 and 11 months
Presence of at least one risk factor: 10° less passive external shoulder rotation compared to the other side or a score below 6 on active movement scales for shoulder external rotation, abduction, elbow flexion, or supination
Signed consent form by parent(s) who are over 18 years old
You will not qualify if you...
Bilateral obstetrical brachial plexus palsy
Planned microsurgery or muscle surgery between 12 and 18 months
Contraindications to botulinum toxin use
Contraindications to MRI
MRI not possible due to sedation issues or organizational constraints
Parents unable to provide consent
Parents under 18 years old
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Treatment
Duration - Single treatment at 12 months
Participants receive an injection procedure at 12 months of age, either botulinum toxin type A or a sham injection.
1 injection visit (in-person)
Follow-up
Duration - From 12 to 18 months of age
Participants are monitored to assess the effects of the treatment on shoulder deformity, muscle condition, and upper limb function.
Visits at 18 months of age for outcome assessments
Long-term Monitoring
Duration - From 2 to 10 years of age
Participants are followed annually to determine the frequency and type of any surgical interventions up to 10 years of age.
Annual visits for surgical intervention monitoring
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Effectiveness and safety of early intramuscular botulinum toxin injections to prevent shoulder deformity in babies with brachial plexus birth injury (POPB-TOX), a randomised controlled trial: study protocol.